IRADIMED CORPORATION IRMD
88.58 USD +7.47 (+9.21%)
At closeNov 4, 2026, 4:01 PM EST
88.58 0.00 0.00%
After hours · Nov 4, 4:01 PM ET
82.73 Day range 89.17
76.35 52-week range 107.90
- YTD
- -8.94%
- 1 year
- +2.12%
Analyst view
Consensus: buy
Buy
Price target (mean) 118.00 +33.2% upside
Now 88.58
- Target (low)
- 116.00
- Target (mean)
- 118.00
- Target (high)
- 120.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.60 | 0.59 – 0.61 | 0.54 | +11.1% | 25.57M | +12.7% | 3 |
| Next quarter | 0.57333 | 0.56 – 0.59 | 0.49 | +17.0% | 24.55M | +11.7% | 3 |
| Current year | 2.10 | 2.09 – 2.11 | 1.93 | +8.6% | 91.93M | +9.7% | 3 |
| Next year | 2.44 | 2.41 – 2.47 | 2.10 | +16.2% | 102.30M | +11.3% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 2026 | Needham | Initiated | — | Hold |
| Apr 2, 2026 | Freedom Broker | Initiated | — | Buy |
| Feb 14, 2025 | Roth MKM | Reiterated | Buy | Buy |
| Aug 2, 2024 | Roth MKM | Maintained | Buy | Buy |
| Aug 2, 2021 | Roth Capital | Maintained | — | Buy |
| Jul 31, 2017 | Roth Capital | Upgrade | Neutral | Buy |
| Oct 5, 2016 | Roth Capital | Downgrade | Buy | Neutral |
| Apr 4, 2016 | Roth Capital | Maintained | — | Buy |
| Jun 16, 2015 | Roth Capital | Maintained | — | Buy |
| Aug 11, 2014 | Roth Capital | Initiated | — | — |